date:May 08, 2012
L Bryant at the US District Court for the Northern District of Connecticut told the FDA to go back to the drawing board in a high-profile ruling in February.
She said: There are less burdensome ways in which the FDA could indicate in a short, succinct and accurate disclaimer that it has not approved the claim without nullifying the claim altogether.
Emord: FDA is still using a forbidden qualitative qualifier: very little scientific evidence
However, Jonathan Emord told NutraIngredients-